Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Fibrosis | 1 | 2023 | 503 | 0.660 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 953 | 0.470 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 1235 | 0.440 |
Why?
|
| Fenofibrate | 1 | 2023 | 88 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2024 | 15341 | 0.200 |
Why?
|
| Cosmetics | 1 | 2022 | 102 | 0.190 |
Why?
|
| No-Reflow Phenomenon | 1 | 2020 | 16 | 0.180 |
Why?
|
| Heart Injuries | 1 | 2022 | 205 | 0.180 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2021 | 165 | 0.180 |
Why?
|
| Cosmetic Techniques | 1 | 2022 | 140 | 0.180 |
Why?
|
| Corneal Opacity | 1 | 2020 | 49 | 0.170 |
Why?
|
| Tattooing | 1 | 2020 | 57 | 0.170 |
Why?
|
| Respiratory Sounds | 1 | 2023 | 688 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 321 | 0.150 |
Why?
|
| Intermittent Claudication | 1 | 2020 | 304 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 686 | 0.150 |
Why?
|
| Fertility | 1 | 2021 | 769 | 0.130 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 610 | 0.130 |
Why?
|
| Vasodilation | 1 | 2020 | 956 | 0.130 |
Why?
|
| Metals | 1 | 2020 | 708 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2023 | 1367 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3751 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2020 | 1177 | 0.100 |
Why?
|
| Prostatectomy | 1 | 2021 | 1905 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 2224 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 1255 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 11215 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3269 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3282 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 15010 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4414 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2020 | 6321 | 0.070 |
Why?
|
| Disease Progression | 1 | 2023 | 13302 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5050 | 0.060 |
Why?
|
| Lung | 1 | 2023 | 9843 | 0.060 |
Why?
|
| Humans | 18 | 2024 | 746070 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6456 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2023 | 163 | 0.050 |
Why?
|
| Africa, Northern | 1 | 2022 | 83 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8302 | 0.050 |
Why?
|
| Galectin 3 | 1 | 2023 | 238 | 0.050 |
Why?
|
| Middle East | 1 | 2022 | 219 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11655 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15367 | 0.050 |
Why?
|
| Ankle Brachial Index | 1 | 2020 | 150 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11085 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2022 | 635 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 468 | 0.040 |
Why?
|
| Hyperemia | 1 | 2020 | 220 | 0.040 |
Why?
|
| Female | 5 | 2024 | 382129 | 0.040 |
Why?
|
| Cough | 1 | 2022 | 584 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2023 | 612 | 0.040 |
Why?
|
| Troponin I | 1 | 2022 | 623 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 1321 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2020 | 555 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2020 | 889 | 0.040 |
Why?
|
| Patients | 1 | 2023 | 898 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1519 | 0.030 |
Why?
|
| Fever | 1 | 2022 | 1604 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2020 | 2918 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2020 | 1559 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2021 | 1265 | 0.030 |
Why?
|
| Male | 5 | 2023 | 351098 | 0.030 |
Why?
|
| Androgens | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2020 | 2104 | 0.030 |
Why?
|
| Prognosis | 2 | 2023 | 29072 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 1415 | 0.030 |
Why?
|
| Cornea | 1 | 2020 | 1336 | 0.030 |
Why?
|
| Lipids | 1 | 2022 | 3290 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8434 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3282 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 3704 | 0.020 |
Why?
|
| Oxygen | 1 | 2021 | 4175 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2022 | 5139 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6831 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2020 | 4514 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9596 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14537 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 10095 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10348 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 53219 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7935 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5697 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63664 | 0.010 |
Why?
|
| Middle Aged | 3 | 2022 | 214419 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15539 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23454 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25174 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 39589 | 0.010 |
Why?
|
| Child | 1 | 2022 | 78469 | 0.010 |
Why?
|
| United States | 1 | 2021 | 70368 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72413 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 164222 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_